Director Brian N. Sheth and investment entities affiliated with him have recently executed notable purchases of Blend Labs, Inc.'s (NASDAQ:BLND) Class A Common Stock. These transactions, which were formally reported through a Form 4 filing, took place over a short period from May 11 to May 13, 2026.
The timing and scale of these acquisitions are noteworthy because they occurred while the stock was trading close to its 52-week low of $1.31. Furthermore, the preceding week had seen shares decline by nearly 10%, indicating a period of market weakness for BLND. Despite this downward pressure, the purchases totaled approximately $2.79 million.
Details of the Acquisition Activity
The bulk of these newly acquired shares were purchased by Haveli Brooks Aggregator, L.P., an entity that has connections to Mr. Sheth and other investments managed under the Haveli umbrella. The total number of shares acquired through this vehicle amounted to 1,951,635 shares. These purchases spanned a range of prices, specifically from $1.3371 up to $1.465 per share.
On May 11, 2026, the acquisition involved 395,915 shares, purchased at a weighted average price of $1.4073 per share.
The following day, May 12, 2026, saw the acquisition of an additional 258,796 shares, with a weighted average purchase price of $1.4138 per share.
The largest single transaction was recorded on May 13, 2026. On this day, 1,296,924 shares were acquired at a weighted average price of $1.4392 per share.
It is important to note that these shares are held indirectly by Haveli Brooks Aggregator, L.P. Beyond this primary entity, Mr. Sheth also maintains an indirect holding of 130,000 shares through a family trust. Furthermore, the article points out several other related entities - including Haveli Investments Software Fund I GP, LLC, Whanau Interests LLC, Haveli Software Management LLC, Haveli Investment Management LLC, and Haveli Investments, L.P. - which may share voting and disposition power over these securities.
Following the completion of these purchases, Haveli Brooks Aggregator, L.P. now reports a holding of 12,800,508 shares of Blend Labs Class A Common Stock. This significant accumulation suggests continued internal conviction in the company's valuation, particularly given the current market environment.
Contextual Financial Performance and Valuation
In separate financial news, Blend Labs recently released its first-quarter 2026 financial results, which presented a mixed picture for the firm. The company reported total revenue of $30.8 million. This figure surpassed the consensus estimate set at $30.0 million and represented a notable 15% increase when compared to the same period in the previous year.
However, the earnings per share (EPS) derived from continuing operations were reported at $0.00. While this aligned with general consensus estimates, it failed to meet certain forecasts that had projected an EPS of $0.01. This contrast highlights a divergence: strong revenue growth juxtaposed against difficulties in meeting expectations for core profitability.
The market response reflected these mixed results. Following the announcement, Citizens, an analyst firm, adjusted its outlook by lowering its price target for Blend Labs from $5.00 down to $4.00. Nevertheless, the firm maintained a rating of Market Outperform on the stock. The combination of revenue strength and profitability challenges suggests that while operational top-line growth is occurring, optimizing core earnings remains an area of concern.
The activity reported by Mr. Sheth's affiliated entities comes against a backdrop where other market signals suggest internal interest. For instance, an InvestingPro tip noted that management has been engaging in aggressive share buybacks, which aligns conceptually with the recent insider purchasing activity observed through Form 4 filings. Furthermore, current analysis suggests that the stock may be undervalued at its existing levels, citing a Fair Value of $1.48 according to one platform's assessment.
Risks
- The stock is trading near its 52-week low of $1.31 and declined nearly 10% the prior week.
- BLND's Q1 2026 earnings per share (EPS) from continuing operations were reported at $0.00, failing to meet certain forecasts that projected $0.01.
- The analyst firm Citizens lowered its price target for BLND from $5.00 to $4.00 following the financial results.
More from Insider Trading